Skip to main content

Advertisement

Table 3 WA productivity loss and indirect costs in propensity score matched cohorts with WA eligibility

From: Productivity loss and indirect costs associated with cardiovascular events and related clinical procedures

Measure Patients with WA eligibility
With CVERP Without CVERP p-value
N = 5,808 N = 5,808  
n/mean %/SD n/mean %/SD  
During the 1st month of follow-up:      
Patients reporting WA (n, %) 4,011 69.1 3,963 68.2 0.34
Monthly hours lost due to WA (mean, SD) 43.0 50.8 19.7 27.8 <.001
Indirect costs associated with WA (mean, SD) $1,267 $1,511 $585 $849 <.001
Patients with ≥ 1 year of follow-up (n, %) 3,905 67.2 4,332 74.6  
During the 1st year of follow-up:      
Patients reporting WA (n, %) 3,370 86.3 3,742 86.4 0.92
Monthly hours lost due to WA (mean, SD) 23.1 21.2 19.8 17.3 <.001
Indirect costs associated with WA (mean, SD) $698 $666 $597 $548 <.001
Patients with ≥ 2 years of follow-up (n, %) 2,672 46.0 3,053 52.6  
During the 2nd year of follow-up:      
Patients reporting WA (n, %) 2,255 84.4 2,643 86.6 0.02
Monthly hours lost due to WA (mean, SD) 19.2 16.1 19.4 16.5 0.62
Indirect costs associated with WA (mean, SD) $565 $483 $573 $508 0.54
Patients with ≥ 3 years of follow-up (n, %) 1,826 31.4 2,101 36.2  
During the 3rd year of follow-up:      
Patients reporting WA (n, %) 1,552 85.0 1,788 85.1 0.92
Monthly hours lost due to WA (mean, SD) 19.0 15.8 19.1 17.0 0.86
Indirect costs associated with WA (mean, SD) $548 $465 $551 $491 0.84
  1. CVERP: cardiovascular events and related clinical procedures; SD: standard deviation; WA: workplace absenteeism